Don’t forget you can visit MyAlerts to manage your alerts at any time.
By Colleen Murphy | February 9, 2024
"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read
By Colleen Murphy | February 8, 2024
This suit was surfaced by Law.com Radar, ALM's source for immediate alerting on just-filed cases in state and federal courts. Law.com Radar now offers state court coverage nationwide. Sign up today and be among the first to know about new suits in your region, practice area or client sector.
4 minute read
By Brian Lee | February 5, 2024
Chief Judge Elizabeth Wolford of U.S. District Court, Western District in Rochester wrote that the plaintiffs failed to present a viable claim under the Sherman Act.
4 minute read
By Adolfo Pesquera | February 5, 2024
In the agreed judgement, Publicis Health does not admit any wrongdoing that was alleged by the attorney general.
3 minute read
By Amanda Bronstad | February 2, 2024
On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered 55 cases filed against Eli Lilly and Novo Nordisk over Ozempic, Mounjaro and other medications be coordinated into multidistrict litigation.
3 minute read
By Charles Toutant | January 29, 2024
On Sept. 12, 2023, the FDA issued a report on phenylephrine, saying that there were no safety issues found with its use as a decongestant but there were also no benefits, the suit said.
3 minute read
By Amanda Bronstad | January 26, 2024
About 50 lawsuits so far target Novo Nordisk and Eli Lilly over Type 2 diabetes medications Ozempic, Mounjaro and other medications. Lawyers anticipate 10,000 to 20,000 cases.
7 minute read
By Maria Dinzeo | January 22, 2024
Tris Pharma targets ADHD and addiction, while BPGbio uses an AI platform to discover drug candidates.
5 minute read
By Charles Toutant | January 19, 2024
Courts have consistently rejected challenges under the Takings Clause to federal health care programs that seek to limit costs, according to an amicus curiae brief by a panel of nine nationally recognized experts in Medicare and medical finance.
5 minute read
Delaware Business Court Insider
By Ross Todd | January 19, 2024
Since 2020, Desmarais LLP partner Kerri-Ann Limbeek has represented prenatal testing client Ravgen in eight patent cases in district court and at the Patent Trial and Appeal Board. This week, in her first time as lead counsel at trial, she won a $57 million infringement verdict for the company.
7 minute read
The Legal Intelligencer honors lawyers leaving a mark on the legal community in Pennsylvania and Delaware.
Consulting Magazine recognizes leaders in technology across three categories Leadership, Client Service and Innovation.
Celebrate outstanding achievement in law firms, chambers, in-house legal departments and alternative business structures.
Health Law Associate CT Shipman is seeking an associate to join our national longstanding health law practice. Candidates must have t...
Shipman & Goodwin LLP is seeking two associates to expand our national commercial real estate lending practice. Candidates should have ...
Epstein Becker & Green is seeking an associate to joins its Commercial Litigation practice in our Columbus or Cincinnati offices. Ca...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS